Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb 10;10(2):e00978.
doi: 10.14309/crj.0000000000000978. eCollection 2023 Feb.

Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis

Affiliations
Case Reports

Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis

Patrick P Y Chan et al. ACG Case Rep J. .

Abstract

Epstein-Barr virus-associated mucocutaneous ulcer is a rare lymphoproliferative disorder that occurs in immunosuppressed states that can develop in the gastrointestinal tract and mimic inflammatory bowel disease or other malignancies. We present the case of a 61-year-old man who presented with concurrent acute severe ulcerative colitis and colonic Epstein-Barr virus-associated mucocutaneous ulcer requiring rituximab therapy and a subtotal colectomy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Perianal ulcer, (B) severe ulcerative colitis of the rectum (left), (C) relative sparing of the sigmoid colon (right), and (D) ulcerated descending colon mass with spontaneous bleeding.
Figure 2.
Figure 2.
(A) Hematoxylin and eosin staining of the descending colon biopsy specimen (magnification ×40). Moderate amount of mixture of inflammatory cell infiltrate in the lamina propria with associated cryptitis consistent with active chronic colitis. Associated large monomorphic atypical cells with vesicular nuclei and prominent nucleoli arranged in sheets. (B) EBV-encoded small RNA in situ hybridization (EBER-ISH) probe identified EBV-positive cells (right). EBV, Epstein-Barr virus.

References

    1. Beaugerie L, Brousse N, Bouvier AM, et al. . Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study. Lancet 2009;374(9701):1617–25. - PubMed
    1. Roberts TK, Chen X, Liao JJ. Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: A case report and systematic review of the literature. Exp Hematol Oncol 2015;5:13–4. - PMC - PubMed
    1. Goetgebuer RL, van der Woude CJ, de Ridder L, Doukas M, de Vries AC. Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: An illustrative case series. Int J Colorectal Dis 2019;34(5):923–6. - PubMed
    1. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer–a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 2010;34(3):405–17. - PMC - PubMed
    1. Montes L, Tredez E, Yzet C, et al. Epstein-Barr Virus-related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti-CD30. Clin Case Rep 2020;8(6):958–61. - PMC - PubMed

Publication types